The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 02, 2026

Filed:

Nov. 17, 2022
Applicant:

Beijing Balance Medical Technology Co., Ltd., Beijing, CN;

Inventors:

Lei Jin, Beijing, CN;

Lai Wei, Beijing, CN;

Kangjian Wu, Beijing, CN;

Jia Wu, Beijing, CN;

Zhihao Fan, Beijing, CN;

Liyan Li, Beijing, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/24 (2006.01);
U.S. Cl.
CPC ...
A61F 2/2409 (2013.01); A61F 2/2433 (2013.01); A61F 2210/0009 (2013.01); A61F 2210/0014 (2013.01); A61F 2210/0076 (2013.01); A61F 2220/0008 (2013.01); A61F 2230/0067 (2013.01); A61F 2230/0069 (2013.01); A61F 2230/0093 (2013.01); A61F 2240/002 (2013.01); A61F 2250/006 (2013.01);
Abstract

A split type precisely-anchorable transcatheter valve-in-ring system comprises a split transcatheter valve-in-ring anchoring stent () and a transcatheter artificial biological valve-in-ring (), wherein the shape and structure of the transcatheter valve-in-ring anchoring stent () are matched with the real structure of the annuloplasty ring and supravalvular and infravalvular tissues after three-dimensional reconstruction based on imaging data of a patient who have undergone valve failure after implantation of a annuloplasty ring (), the transcatheter valve-in-ring anchoring stent () is firstly delivered to the patient's failed annuloplasty ring for release, deformation and alignment with the supravalvular and infravalvular tissues of the failed annuloplasty ring; the transcatheter artificial biological valve-in-ring () is delivered to the transcatheter valve-in-ring anchoring stent () for release, the stent of the transcatheter artificial biological valve-in-ring () deforms and expands to the functional state of the transcatheter valve-in-ring, causing the transcatheter valve-in-ring anchoring stent () to deform again and combine with the expanded transcatheter valve-in-ring, and meanwhile, the re-deformation of the transcatheter valve-in-ring anchoring stent () causes the transcatheter valve-in-ring anchoring stent () to combine with the subvalvular structure again and anchor.


Find Patent Forward Citations

Loading…